by admin | Dec 23, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Nature Italy By studying how hematopoietic stem cells respond to age and damage, Raffaella di Micco aims to anticipate the long-term effects of some gene therapies. This is a scene from my daily routine in my lab in Milan where we study hematopoietic stem cells,...
by admin | Dec 22, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By The Ottawa Hospital – The Globe and Mail Treatment developed at The Ottawa Hospital can halt MS progression and potentially reverse symptoms When Geneviève Bétournay developed blurry vision and pain in her hips 12 years ago, she was shocked to be diagnosed...
by admin | Dec 21, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Medical News Life Sciences Researchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) have used CRISPR/Cas9 technology to engineer donor T cells to try to treat seriously ill children with...
by admin | Dec 20, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Genetic Engineering & Biotechnology News A study by scientists at the Icahn School of Medicine at Mount Sinai, the James J. Peters Veterans Affairs Medical Center, the Yale School of Medicine, and the New York Stem Cell Foundation Research Institute (NYSCF)...
by admin | Dec 19, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Frances Stead Sellers – The Washington Post For the burgeoning population of covid long-haulers, there is an abundance of new treatment options: Specially formulated nutraceuticals imported from India that promise to “get you life back from covid.” Pure...
by admin | Dec 16, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by By Beth JoJack – Medical News Today For the first time, researchers have used CRISPR gene-editing technology to substitute a gene in a patient’s immune cells to redirect those cells to fight cancer. Details of a small human clinical trial using this approach...
